Several treatments are now available to fight COVID-19 but tight timelines, unequal access and weakening effectiveness against new variants have limited their ability to blunt the worst of the pandemic.
May 1, 2022
0
39
Mylan will pay $465 million to resolve accusations from some regulators that it overbilled the federal Medicaid program for the EpiPen allergy medication, the drugmaker announced Friday.
Oct 7, 2016
0
5
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0
(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.
Aug 9, 2018
0
0
Israeli pharmaceutical giant Teva vowed Saturday to defend itself after being accused of orchestrating price-fixing among drugmakers in a US antitrust lawsuit.
May 11, 2019
0
0
Merck and Sanofi Pasteur are ending their partnership, begun in 1994, to market the drugmakers' vaccines in Europe.
Mar 8, 2016
0
0
Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain for some patients, but an advocacy group says much bigger changes are needed.
Mar 4, 2019
0
3
The Food and Drug Administration says it has approved the first generic versions of the blockbuster antidepressant drug Cymbalta, offering lower-cost access to one of the most widely prescribed treatments for depression, ...
Dec 11, 2013
0
0
The Food and Drug Administration is seeking a rule change to allow generic drugmakers to quickly update their warning labels with new safety information for doctors and patients.
Nov 8, 2013
0
0
Drugmaker Pfizer said Monday that it will launch a less-expensive version of rival Johnson & Johnson's blockbuster immune disorder drug, Remicade.
Oct 18, 2016
0
0
